Montreal Cognitive Assessment (MoCA) performance in Huntington's disease patients correlates with cortical and caudate atrophy

PeerJ. 2022 Apr 4:10:e12917. doi: 10.7717/peerj.12917. eCollection 2022.

Abstract

Huntington's Disease (HD) is an autosomal neurodegenerative disease characterized by motor, cognitive, and psychiatric symptoms. Cognitive impairment develops gradually in HD patients, progressing later into a severe cognitive dysfunction. The Montreal Cognitive Assessment (MoCA) is a brief screening test commonly employed to detect mild cognitive impairment, which has also been useful to assess cognitive decline in HD patients. However, the relationship between MoCA performance and brain structural integrity in HD patients remains unclear. Therefore, to explore this relationship we analyzed if cortical thinning and subcortical nuclei volume differences correlated with HD patients' MoCA performance. Twenty-two HD patients and twenty-two healthy subjects participated in this study. T1-weighted images were acquired to analyze cortical thickness and subcortical nuclei volumes. Group comparison analysis showed a significantly lower score in the MoCA global performance of HD patients. Also, the MoCA total score correlated with cortical thinning of fronto-parietal and temporo-occipital cortices, as well as with bilateral caudate volume differences in HD patients. These results provide new insights into the effectiveness of using the MoCA test to detect cognitive impairment and the brain atrophy pattern associated with the cognitive status of prodromal/early HD patients.

Keywords: Brain atrophy; Caudate volume; Cortical thickness; Huntington’s disease; MoCA test.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atrophy / complications
  • Cerebral Cortical Thinning
  • Humans
  • Huntington Disease* / complications
  • Mental Status and Dementia Tests
  • Neurodegenerative Diseases* / complications

Associated data

  • figshare/10.6084/m9.figshare.15161562
  • figshare/10.6084/m9.figshare.15161199
  • figshare/10.6084/m9.figshare.15161190

Grants and funding

This study was supported by CONACYT–Mexico grant No. A1-S-10669 and PAPIIT-UNAM grant No. IN220019 to Juan Fernandez-Ruiz. CONACYT–Mexico Ph.D. fellowship No. 369794 and grant Fondo semilla-2019 No. CIP-PI-029-2018-2 from FCS-Universidad Panamericana given to Victor Galvez (CVU: 421958). Ramirez-Garcia received a doctoral (Programa de Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de Mexico) fellowship 574022/403010 (CVU: 660496) and postdoctoral fellowship No. CB-2017-2018-A1-S-10669-M-5248 by the Fondo Sectorial de Investigación para la Educación Básica from CONACYT–Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.